Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 February 2019 | Story Ruan Bruwer
Tharina van der Walt
The hammer thrower Tharina van der Walt is one of several first-class athletes among the first-year students at Kovsies this year. She is the South African U18 champ and record-holder in 2018.

Several top athletes, some of whom were the very best in the country in their respective events at school, have joined Kovsies as first-year students. They already had their first taste of glory as Kovsies when they recently won their events at the first-year meeting.
 
Among these first-years are Jannes Schlebusch (javelin thrower), Joviale Mbisha (sprinter), Colette Uys (discus/shot-put), and Tharina van der Walt (hammer thrower), who have all represented South Africa in the past two years.
 
Schlebusch won the silver medal at the World U18 championships in 2017, but was injured last year. Great things were expected for 2019, but during the first-year meeting he injured his ankle to such an extent that he will have to undergo an operation that would put him on the sideline for the rest of the season.
 
Van der Walt was the South African schools champ in the hammer throw for girls U19 in 2018, when she managed to set up a new school record of 57,83 m. She was ranked fourth at the World U18 champs in 2017. At the same meeting, Mbisha ended 14th in the 100 m.
 
Uys, who participated in the CAA Southern Region Youth and Junior Championships last year, achieved a second place in the discus at the 2018 National Secondary Schools Championships for girls U19. Other first-years who took part in the SA’s last year, are Vicky Oelofse (1 500 m) and Michael Skosana (long jump).
 
They will strengthen Kovsie Athletics, which already boasts a large group of athletes with international experience. Of the 16 athletes who participated internationally last year, only Kesa Molotsane and Lara Orrock will not be in action for the students again.
 
■ Imperium Residence won the men’s division and Arista/Amelia were the ladies’ winners.
 

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept